1. Research Objectives and Assumptions

   • Research Objectives
   • Assumptions
   • Abbreviations

2. Market Overview

   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • U.S. Influenza Vaccines Market, By Vaccine Type
     • U.S. Influenza Vaccines Market, By Virus Type
     • U.S. Influenza Vaccines Market, By Age Group

3. Market Dynamics, Regulations, and Trends Analysis

   • Market Dynamics
   • Impact Analysis
   • Key Highlights
   • Regulatory Scenario
   • Product Launches/Approvals
   • PEST Analysis
   • PORTER’s Analysis
   • Market Opportunities
   • Regulatory Scenario
   • Key Developments
   • Industry Trend

4. U.S. Influenza Vaccines Market, By Vaccine Type, 2020-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 - 2033
     • Segment Trends
   • Trivalent Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
   • Quadrivalent Vaccines
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

5. U.S. Influenza Vaccines Market, By Virus Type, 2020-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 - 2033
     • Segment Trends
   • Influenza Virus Type A
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
   • Influenza Virus Type B
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

6. U.S. Influenza Vaccines Market, By Age Group, 2020-2033, (USD Bn)

   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2021 - 2033
     • Segment Trends
   • Pediatrics
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)
   • Adults
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2020-2033, (USD Bn)

7. Competitive Landscape

   • Seqirus USA Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • GSK plc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Sanofi
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Pfizer Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • AstraZeneca
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Novartis AG
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Merck & Co., Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Protein Sciences Corporation
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Moderna, Inc.
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • INOVIO Pharmaceuticals
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • Novavax
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies
   • EMERGENT
     • Company Highlights
     • Product Portfolio
     • Key Developments
     • Financial Performance
     • Strategies

8. Analyst Recommendations

   • Wheel of Fortune
   • Analyst View
   • Coherent Opportunity Map

9. References and Research Methodology

   • References
   • Research Methodology
   • About us